Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Psychotic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03192631
What this trial is testing

Financial Incentives to Improve Acceptance of Antipsychotic Injections

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Focus Community Mental Health Team 20
Not applicableStudy completedNCT02118610
What this trial is testing

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 63
Not applicableStudy completedNCT01793935
What this trial is testing

Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
K.N. Roy Chengappa 68
Large-scale testing (Phase 3)Study completedNCT00101634
What this trial is testing

Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 518
Testing effectiveness (Phase 2)Study completedNCT01266174
What this trial is testing

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

Who this might be right for
Cognitive ImpairmentSchizophrenia
Amarantus BioScience Holdings, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT01716858
What this trial is testing

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Chiba University 10
Testing effectiveness (Phase 2)Study completedNCT00074477
What this trial is testing

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 250
Not applicableUnknownNCT02877108
What this trial is testing

Naturalistic Adasuve Clinical Trial Study

Who this might be right for
Agitation
Mt Sinai Hospital, Chicago 100
Large-scale testing (Phase 3)Ended earlyNCT01363349
What this trial is testing

Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia

Who this might be right for
SchizophreniaCognitive Effect on Schizophrenic Patients
BioLineRx, Ltd. 269
Post-approval studies (Phase 4)WithdrawnNCT00964041
What this trial is testing

Once Weekly D-cycloserine for Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT01602029
What this trial is testing

Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 303
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Not applicableNot Yet RecruitingNCT06563752
What this trial is testing

Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers

Who this might be right for
Schizophrenia
National Yang Ming Chiao Tung University 360
Not applicableStudy completedNCT00543088
What this trial is testing

Effectiveness of Anti-Psychotic in GPs Setting

Who this might be right for
SchizophreniaBipolar Disorder
AstraZeneca 250
Testing effectiveness (Phase 2)Study completedNCT00000281
What this trial is testing

Pharmacotherapy for Schizophrenic Drug Users - 6

Who this might be right for
Cocaine-Related DisordersSubstance-Related DisordersShcizophrenia
Yale University
Post-approval studies (Phase 4)Study completedNCT00334035
What this trial is testing

Antipsychotic Therapy and First Episode

Who this might be right for
Schizophrenia
The University of Hong Kong 169
Testing effectiveness (Phase 2)Study completedNCT00483964
What this trial is testing

A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia

Who this might be right for
Schizophrenia
Q.Mundewadi Ayurvedic Research & Charitable Trust 200
Not applicableStudy completedNCT03183609
What this trial is testing

Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)

Who this might be right for
SchizophreniaGluten SensitivitySchizo Affective Disorder
University of Maryland, Baltimore 40
Testing effectiveness (Phase 2)Study completedNCT00125138
What this trial is testing

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychotic Disorders
Lundbeck LLC 90
Early research (Phase 1)Study completedNCT00698022
What this trial is testing

A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers

Who this might be right for
Healthy
Corcept Therapeutics 76
Next Page